ARTICLE | Clinical News
Remitch nalfurafine regulatory update
June 8, 2015 7:00 AM UTC
Japan’s Ministry of Health, Labor and Welfare (MHLW) approved an expanded label for Remitch nalfurafine from Toray to include improvement of pruritus in patients with chronic liver disease. The kappa opioid receptor ( KOR) agonist is approved to treat pruritus in hemodialysis patients. ...